Class 1 Integrons Increase Trimethoprim-Sulfamethoxazole MICs against Epidemiologically Unrelated Stenotrophomonas maltophilia Isolates

AUTOR(ES)

Barbolla, Raquel

FONTE

American Society for Microbiology

RESUMO

Twenty-five plasmid-specified antimicrobial resistance determinants common to gram-negative bacilli from nosocomial infection were investigated from 31 Stenotrophomonas maltophilia isolates. Twenty-four clones were identified by pulsed-field gel electrophoresis, and in three clones that exhibited an increased trimethoprim-sulfamethoxazole MIC, the sul1 determinant was found. These results support not only the higher spread of class 1 integrons compared to other mechanisms but also the potential limitation of using trimethoprim-sulfamethoxazole for therapy of severe S. maltophilia infections.

Documentos Relacionados

• In Vitro Killing Effect of Moxifloxacin on Clinical Isolates of Stenotrophomonas maltophilia Resistant to Trimethoprim-Sulfamethoxazole
• In Vitro Susceptibility of Pseudomonas cepacia and Pseudomonas maltophilia to Trimethoprim and Trimethoprim-Sulfamethoxazole
• Biofilm Formation by Stenotrophomonas maltophilia: Modulation by Quinolones, Trimethoprim-Sulfamethoxazole, and Ceftazidime
• Trimethoprim-Sulfamethoxazole in Murine Toxoplasmosis
• Clinical Pharmacology of Intravenously Administered Trimethoprim-Sulfamethoxazole